James is a co-founder of Thomas, McNerney & Partners and has been investing in health care companies since 1992. James previously headed Warburg Pincus LLC's medical technology private equity practice, where he had responsibility for investments in biotechnology, pharmaceutical, medical device and diagnostic companies. Prior to joining Warburg, James was a Vice President at Goldman Sachs International in London. He is currently a board member of Clarus Therapeutics, Inc. Historical investments include: American Medical Systems Holdings, Inc. (AMMD), CAS Medical Systems, Inc. (CASM sold to Edwards Lifesciences), Coley Pharmaceutical Group, Inc. (COLY sold to Pfizer), Galil Medical Ltd. (sold to BTG), The Medicines Company (MDCO), OsteoBiologics, Inc. (sold to Smith & Nephew), PCI Pharma Services, Inc. (sold to Partners Group), Torax Medical, Inc. (sold to Johnson & Johnson), Transkaryotic Therapies, Inc. (TKTX sold to Shire Pharmaceuticals Group), Visible Genetics, Inc., Wright Medical Group, Inc. (WMGI), and Xomed Surgical Products, Inc. (XOMD sold to Medtronic). James graduated magna cum laude with a B.S. in Economics from the Wharton School at the University of Pennsylvania and received an M.Sc. in Economics from the London School of Economics.